Tracy I. George, MD

Tracy I. George, MD discusses the effect of Bezuclastinib on the pathobiology of mastocytosis: changes in BM mast cells, Tryptase, and KIT p.D816V variant allele frequency from the pivotal summit trial

Tracy George, MD, discusses the findings from the SUMMIT trial and what they mean for patients with non-advanced systemic mastocytosis.

Tracy I. George, MD, discusses and how ultra-sensitive duplex sequencing may address key limitations of current diagnostic tools for indolent systemic mastocytosis.